Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement

Virus Genotype ◽

Genotype 4 ◽

Stiffness Measurement ◽

Impact of Hepatitis C Virus (HCV) Eradication Following Direct Acting Antivirals Treatment (DAA) on Liver Stiffness Measurement (LSM)

Gastroenterology ◽

10.1016/s0016-5085(17)33725-3 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1105-S1106

Author(s):

Mohammed Tag-Adeen S. Khalil ◽

Ahlam M. Sapra ◽

Yuko Akazawa ◽

Ken Ohnita ◽

Kazuhiko Nakao

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Liver Stiffness ◽

Stiffness Measurement ◽

Serum MicroRNAs as predictors for fibrosis progression and response to direct‐acting antivirals treatment in hepatitis C virus genotype‐4 Egyptian patients

International Journal of Clinical Practice ◽

10.1111/ijcp.13954 ◽

2020 ◽

Author(s):

Rasha M. M. Khairy ◽

Safaa Said Hmmad ◽

Mohamed Sayed ◽

Hazem A. Ahmed ◽

Mona Abdel Monem Esmail

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Genotype ◽

Genotype 4 ◽

Fibrosis Progression ◽

Egyptian Patients ◽

Direct Acting ◽

Serum Micrornas

4CPS-085 Assessment of the direct-acting antivirals used to treat the hepatitis c virus genotype 4 infection in a tertiary hospital

10.1136/ejhpharm-2018-eahpconf.176 ◽

2018 ◽

Author(s):

JC del Río Valencia ◽

L Villalobos Torres ◽

R Asensi Diez ◽

I Muñoz Castillo

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Tertiary Hospital ◽

Virus Genotype ◽

Genotype 4 ◽

Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2018.09.010 ◽

2019 ◽

Vol 53 (1) ◽

pp. 80-83 ◽

Cited By ~ 3

Author(s):

Thuy Nguyen ◽

Sepideh Akhavan ◽

Fabienne Caby ◽

Luminita Bonyhay ◽

Lucile Larrouy ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Next Generation Sequencing ◽

Next Generation ◽

Virus Genotype ◽

Genotype 4 ◽

Direct Acting ◽

Generation Sequencing

Faculty Opinions recommendation of Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969197.793470534 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Genotype ◽

Genotype 1B ◽

Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b

Journal of Medical Virology ◽

10.1002/jmv.24950 ◽

2017 ◽

Vol 90 (2) ◽

pp. 313-319 ◽

Cited By ~ 27

Author(s):

Nobuhiko Ogasawara ◽

Masahiro Kobayashi ◽

Norio Akuta ◽

Yoko Kominami ◽

Shunichiro Fujiyama ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Liver Stiffness ◽

Controlled Attenuation Parameter ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Attenuation Parameter ◽

Genotype 1B ◽

New onset steatosis but not persistent steatosis prevents hepatic fibrosis improvement after viral eradication by direct-acting antiviral therapy (DAAs) in patients with chronic hepatitis C: Evaluation by controlled attenuation parameter (CAP) and liver stiffness measurement LSM

Digestive and Liver Disease ◽

10.1016/j.dld.2020.12.044 ◽

2021 ◽

Vol 53 ◽

pp. S16

Author(s):

A. Cespiati ◽

S. Petta ◽

R. Lombardi ◽

V. Di Marco ◽

V. Calvaruso ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Antiviral Therapy ◽

Liver Stiffness ◽

Controlled Attenuation Parameter ◽

Stiffness Measurement ◽

Direct Acting Antiviral ◽

Direct Acting ◽

New Onset

How to optimize current therapy in hepatitis C virus genotype 1 patients. Predictors of response to interferon-based therapy with second wave direct acting antivirals

Liver International ◽

10.1111/liv.12722 ◽

2014 ◽

Vol 35 ◽

pp. 18-20 ◽

Cited By ~ 2

Author(s):

Lawrence Serfaty

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Current Therapy ◽

Genotype 1 ◽

Virus Genotype ◽

Predictors Of Response ◽

Direct Acting ◽

Second Wave

Reply to: “Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?” and “External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals”

Journal of Hepatology ◽

10.1016/j.jhep.2020.04.023 ◽

2020 ◽

Vol 73 (2) ◽

pp. 472-473

Author(s):

Joan Genescà

Keyword(s):

Hepatocellular Carcinoma ◽

Hepatitis C Virus ◽

Liver Disease ◽

Hepatitis C ◽

External Validation ◽

Liver Stiffness ◽

Hepatocellular Carcinoma Surveillance

Virus Eradication ◽

Stiffness Measurement ◽

Direct-acting antiviral therapy for chronic hepatitis C virus genotype 4 infection: Exploring new regimens

Health Science Reports ◽

10.1002/hsr2.106 ◽

2019 ◽

Vol 2 (3) ◽

pp. e106 ◽

Cited By ~ 1

Author(s):

Hidenori Toyoda

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Therapy ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 4 ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽